MEDICÍNA PRO PRAXI / Med. Praxi. 2024;21(3):177-182 / www.medicinapropraxi.cz 182 ZAZNĚLO NA KONGRESE Kam kráčí kardiovaskulární prevence aneb jak žít déle lypill strategy to improve global secondary cardiovascular prevention: from concept to reality. J Am Coll Cardiol. 2014 Aug 12;64(6):613-621. 14. Selak V, Elley CR, Bullen C, et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ. 2014 May 27;348:g3318. 15. Thom S, Poulter N, Field J, et al; UMPIRE Collaborative Group. Effects of a fixed‑dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013 Sep 4;310(9):918-929. 16. Huffman MD. The Polypill: From Promise to Pragmatism. PLoS Med. 2015 Aug 11;12(8):e1001862. 17. Castellano JM, Pocock SJ, Bhatt DL, et al; SECURE Investigators. Polypill Strategy in Secondary Cardiovascular Prevention. N Engl J Med. 2022 Sep 15;387(11):967-977. 18. Cicero AFG, Fogacci F, Rizzoli E, et al; Brisighella Heart Study Group. Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow‑up. Nutr Metab Cardiovasc, DiS. 2022 Sep;32(9):2246-2254. doi: 10.1016/j.numecd.2022. 06. 017. Epub 2022 Jun 30. PMID: 35843791. Registrace a podrobné informace na www.kongresmediciny.cz MÍSTO KONÁNÍ: Hotel International Brno ODBORNÝ GARANT: prof. MUDr. Miroslav Souček, CSc. 18. 19. 10. 2024 BRNO MÍSTO KONÁNÍ: O2 universum ODBORNÝ GARANT: prof. MUDr. Josef Kautzner, CSc., FESC 1. 2. 11. 2024 PRAHA MÍSTO KONÁNÍ: Congress Center Parkhotel Plzeň ODBORNÝ GARANT: prof. MUDr. Hana Rosolová, DrSc. 29. 30. 11. 2024 PLZEŇ VÝHLED NA PODZIMNÍ KONGRESY MEDICÍNY PRO PRAXI KONGRESY PRAKTICKÝCH LÉKAŘŮ 2024
RkJQdWJsaXNoZXIy NDA4Mjc=